Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row

TARRYTOWN, N.Y., Oct. 24, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) today announced thatSciencemagazine has ranked Regeneron as the #1 employer in the global biopharmaceutical industry in the journal's annual Top Employers Survey for the second year in a row.  This distinction will be celebratedMonday, October 28, in conjunction with a groundbreaking ceremony for two new buildings to be constructed at the Regeneron campus inWestchester County, New York.

U.S. SenatorCharles E. Schumer, U.S. Rep.Nita Lowey, Empire State Development Corp. President & CEOKenneth Adams, and other public officials are scheduled to participate in an event with Regeneron employees that will celebrate the biotechnology company's latest expansion and the emergence of the lowerHudson Valleyas a life sciences cluster.

"Regeneron's tremendous growth and our current expansion plans are undoubtedly thanks to our employees.  If we are the best place to work, it is because we have the best employees and a culture where they feel empowered and challenged," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron.   George D. Yancopoulos, Chief Scientific Officer and President, Regeneron Laboratories, said,  "As we are a company founded on scientific excellence, it is very meaningful to us to be recognized bySciencemagazine two consecutive years now as the top place to work in the industry."

The new facilities, for which site preparation is underway, will include a total of 300,000 square feet of laboratory and office space, with a projected move-in date of third quarter 2015.  The expansion will increase Regeneron's square footage on the campus by more than 40 percent and make it possible for Regeneron to create approximately 400 new full-time jobs inWestchester, where it currently employs more than 1,500.  With a total of over 2,200 employees, including nearly 700 in the Regeneron Industrial Operations and Product Supply group inRensselaer, New YorknearAlbany, Regeneron is the largest biotechnology company inNew York Stateand one of the five largest in the world by market capitalization.

The 2013Sciencesurvey sought to identify the companies with the best reputations as employers, based on 3,656 survey responses from readers ofScienceand other survey invitees.  Survey participants came from North America (81%), Europe (10%), and Asia/Pacific Rim (7%); over 80% worked in private industry.  Details of the rankings and survey results can be found in sciencecareers.org and will be featured in the October 25, 2013 print issue.

About Regeneron PharmaceuticalsRegeneron is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visitwww.regeneron.com.